Our Take
Amsterdam's CradleBio just locked in a $73M Series B to build what they're calling the future of protein engineering — and honestly, after watching biotech founders fumble through lab tools for years, an AI-first approach that actually accelerates protein design instead of just adding another clunky dashboard feels like the move. Jelle Prins and Stef Van Grieken aren't household names yet, but $73M in this market is a loud signal that investors think protein engineering is due for itsGPT moment.
better proteins, faster
Research Notes
AI protein engineering, $73M Series B, Amsterdam/NL based
Key Facts
Category
AI/ML
Stage
Series B Â
Discovered via
startups-gallery
The people behind CradleBio
J
Links
Browse by category
Ai & machine learning (116)Developer tools (77)Productivity (71)Ai (46)Productivity & collaboration (40)Devtools (35)Marketing & sales (28)Design & creative (25)Fintech (24)Media & entertainment (22)Ai/ml (20)Security (18)Infrastructure (17)Education (17)Communication (15)Finance & payments (13)Data & analytics (13)Other (12)Hr & people ops (11)Healthcare (11)
Similar products worth knowing
Want products like this in your inbox every morning?
Five products. Every morning. Written by someone who actually cares whether they're good or not. Free forever, unsubscribe whenever.